Yeast mitochondria contain a minimalist threonyltRNA synthetase (ThrRS) composed only of the catalytic core and tRNA binding domain but lacking the entire editing domain. Besides the usual tRNA Thr 2, some budding yeasts, such as Saccharomyces cerevisiae, also contain a non-canonical tRNA Thr 1 with an enlarged 8-nucleotide anticodon loop, reprograming the usual leucine CUN codons to threonine. This raises interesting questions about the aminoacylation fidelity of such ThrRSs and the possible contribution of the two tRNA Thr s during editing. Here, we found that, despite the absence of the editing domain, S. cerevisiae mitochondrial ThrRS (ScmtThrRS) harbors a tRNA-dependent pretransfer editing activity. Remarkably, only the usual tRNA Thr 2 stimulated pre-transfer editing, thus, establishing the first example of a synthetase exhibiting tRNA-isoacceptor specificity during pre-transfer editing. We also showed that the failure of tRNA Thr 1 to stimulate tRNA-dependent pre-transfer editing was due to the lack of an editing domain. Using assays of the complementation of a ScmtThrRS gene knockout strain, we showed that the catalytic core and tRNA binding domain of ScmtThrRS co-evolved to recognize the unusual tRNA Thr 1. In combination, the results provide insights into the tRNA-dependent editing process and suggest that tRNA-dependent pretransfer editing takes place in the aminoacylation catalytic core.
INTRODUCTION
Accurate transfer of genetic information is of critical significance for cellular function and maintenance. Several steps, including DNA replication, mRNA transcription and protein synthesis, contribute to high accuracy with different levels of fidelity (1) . Protein synthesis is initiated by an ancient group of enzymes, the aminoacyl-tRNA synthetases (aaRSs) containing 20 members in the majority of living species (2) (3) (4) . These enzymes catalyze the ligation of a specific amino acid to their specific tRNA-isoacceptors. This reaction, aminoacylation, is performed by most aaRSs in two successive steps. The first step involves adenosine triphosphate (ATP)-dependent amino acid activation in which an intermediate aminoacyl-(adenosine monophosphate (AMP)) is generated with the release of pyrophosphate. This is followed by the transfer of the activated amino acid moiety from the aminoacyl-AMP to the tRNA (2) .
Protein synthesis, which is the last step in the expression of the genetic code, has a very high level of global fidelity, with a mis-incorporation of only one in every 10 000 codons under normal growth conditions (1) . This high level of fidelity is challenging for some aaRSs, which have to discriminate between different amino acids and metabolites that can be structurally and chemically very similar. This critical paradox has been solved by the evolution of the proofreading (editing) function of some error-prone tRNA synthetases (5, 6) . Editing is critical for translational quality control and its impairment or abolition leads to ambiguities in the genetic code and serious cellular dysfunction (7, 8) . The 'double sieve mechanism' has been proposed to control editing function, in which only mis-activated noncognate amino acids are removed, while access of the cognate residue to the editing active site is blocked by steric exclusion (9) . Editing activity is based on the hydroly-sis of mis-activated aminoacyl-AMPs (pre-transfer editing) and/or the hydrolysis of mis-charged aminoacyl-tRNAs (post-transfer editing) (5) . Pre-transfer editing can be further divided into tRNA-independent and tRNA-dependent types according to whether the aminoacyl-AMP hydrolysis is stimulated by tRNA. Post-transfer editing usually takes place in a separated editing domain, such as the CP1 domain in class Ia aaRSs and the N2 domain of class II threonyl-tRNA synthetase (ThrRS) (5, 6) . Furthermore, tRNA-independent pre-transfer editing is believed to occur in the aminoacylation domain, as illustrated by the hydrolysis of aminoacyl-AMP by glutaminyl-tRNA synthetase (GlnRS), seryl-tRNA synthetase (SerRS), prolyltRNA synthetase (ProRS) and CP1-deprived leucyl-tRNA synthetase (LeuRS) (for a review see (5, 6) ). In contrast, the location of the tRNA-dependent pre-transfer editing site is still under debate and several controversial reports suggest that it is located in the editing domain (10) (11) (12) (13) (14) (15) (16) or in the aminoacylation domain (17) (18) (19) . In addition, most natural aaRSs exhibiting tRNA-dependent pre-transfer editing capacity also possess an editing domain to catalyze posttransfer editing, thus, further complicating the assignment of the active site of tRNA-dependent pre-transfer editing.
The mitochondrion has its own translational system, producing several protein components of respiratory complexes. AaRSs for mitochondrial translation are usually encoded by the nuclear genome and then transported into the mitochondrion; however, most tRNAs are encoded by the mitochondrial genome (20) . For instance, human mitochondria express 22 tRNA-isoacceptors corresponding to 20 amino acids with two tRNAs decoding serine [ (21) . The mechanism underlying the translational quality control of the mitochondrial system is an interesting issue since it directly regulates the precise flow of the mitochondrial genetic code. Human mitochondrial leucyl-tRNA synthetase (hmtLeuRS) has been reported to be defective in post-transfer editing because of a degenerate CP1 domain; however, it has a more rigorous amino acid activation site to exclude non-cognate amino acids (22) . Similarly, in contrast to its bacterial and eukaryotic cytoplasmic counterparts, yeast mitochondrial phenylalanyl-tRNA synthetase (PheRS) harbors no editing domain but selects Phe over Tyr more efficiently (23) .
Components of the translational machinery of some budding yeasts, such as S. cerevisiae, display unique characteristics. First, the canonical leucine (Leu) codon CUN (N: A, G, C, T) is reassigned to threonine (Thr) in the S. cerevisiae mitochondrion (24) , although the evolutionary benefit of this reassignment is unclear. This reassignment is mediated by a structurally unique S. cerevisiae mitochondrial tRNA Thr 1 (tRNA Thr 1) with an enlarged anticodon loop containing the 34 UAG 36 anticodon. The loop enlargement is due to the insertion of U between U33 and the 34 UAG 36 anticodon, which is designated as U33a here ( Figure 1A ) (25 Figure 1A ) (25) . Second, the enzyme catalyzing the aminoacylation of tRNA Thr 1 and tRNA Thr 2, S. cerevisiae mitochondrial ThrRS (ScmtThrRS), encoded by the MST1 gene, is devoid of an editing domain, and consists only of the aminoacylation catalytic core connected to the C-terminal tRNA binding domain (CTD) ( Figure 1B ) (28, 29) . This phenomenon also occurs in the mitochondria of other yeasts, such as S. pombe and C. albicans, although the CUN codons still encode Leu. This phenomenon suggests that loss of the editing domain occurred at a very early stage in the evolution of yeast, while CUN reassignment was a more recent event. In contrast, bacterial, eukaryotic cytoplasmic and other mitochondrial ThrRSs contain a N2 editing domain that hydrolyzes mischarged Ser-tRNA Thr (19, 30) . ScmtThrRS has been reported to mis-activate Ser and to use tRNA-independent pre-transfer editing to remove Ser-AMP (31) . In addition, only ScmtThrRS, but not S. pombe or C. albicans mitochondrial ThrRS (SpmtThrRS or CamtThrRS), recognizes tRNA Thr 1, suggesting the evolution of tRNA Thr 1 recognition elements in ScmtThrRS, which have yet to be identified (27) . Furthermore, whether other ThrRSs, such as bacterial and eukaryotic cytoplasmic, and mitochondrial ThrRSs can recognize the unique tRNA Thr 1 is also unclear. Above all, investigation of the aminoacylation and editing mediated by ScmtThrRS/tRNA
Thr is an interesting model with the two partners developing significant peculiarities during evolution.
In the present study, we showed that ScmtThrRS exhibits a tRNA-dependent pre-transfer editing activity that is specific for the tRNA Thr 2 isoacceptor, whereas tRNA Thr 1 was unable to stimulate such activity. We further confirmed the editing capability of tRNA Thr 1, but demonstrated a requirement for the presence of an editing domain. We also identified the editing determinants of tRNA Thr 2 and the editing antideterminants of tRNA Thr 1. Finally, we constructed a yeast MST1 gene knockout strain and, using a plasmid shuffle assay and different chimeric constructs, we showed that the catalytic core and tRNA binding domain of ScmtThrRS co-evolved to recognize the unusual tRNA Thr 1. In combination, the results of the present study provide insights into the tRNA-dependent editing process and also suggest that tRNA-dependent pre-transfer editing takes place in the aminoacylation catalytic core. . The DNA fragment rapid purification kits and plasmid extraction kits were purchased from YPH (China). KOD-plus mutagenesis kits were obtained from TOYOBO (Japan). T4 DNA ligase and restriction endonucleases were obtained from Thermo Scientific (Pittsburgh, PA, USA). Phusion high-fidelity DNA polymerase was purchased from New England Biolabs (Ipswich, MA, USA). Ni 2+ -NTA Superflow was purchased from Qiagen Inc. (Germany). Polyethyleneimine cellulose plates were purchased from Merck (Germany). Pyrophosphatase (PPiase) was obtained from Roche Applied Science (China). The dNTP mixture was obtained from TaKaRa (Japan). Oligonucleotide primers were synthesized by Invitrogen (China). Escherichia coli BL21 (DE3) cells were purchased from Stratagene (Santa Clara, CA, USA). A diploid yeast strain (BY4743-MST1 +/− ) was obtained from Thermo Scientific. Recombinant plasmid pET28a-SccytThrRS was constructed in our laboratory (19) . C. albicans genome was a gift from Prof. Jiang-Ye Chen in our Institute. p425TEF was kept in our laboratory (19) .
MATERIALS AND METHODS

Materials
Cloning and mutagenesis
The MST1 gene encoding the ScmtThrRS precursor was amplified from the S. cerevisiae genome and cloned into pET28a(+) between the NdeI and XhoI restriction sites. The gene fragment encoding the mature ScmtThrRS without its mitochondrial targeting sequence (MTS) (Met 1 -Ser 31 ) (27) was then subcloned into pET28a(+) using the NdeI and XhoI sites to generate pET28a(+)-ScmtThrRS, from which the mature ScmtThrRS was expressed. Construction of the gene encoding the chimeric S. cerevisiae cytoplasmic-mitochondrial ThrRS (CmThrRS) was performed in two steps. First, the gene encoding the N-terminal fragment of SccytThrRS (Met 1 -Gln 337 , including the Nextension, N1 and N2 domains), was amplified by polymerase chain reaction (PCR) using pET28a-SccytThrRS as a template and cleaved by NdeI and SacI enzymes. Second, the DNA fragment encoding the aminoacylation and C-terminal domains of ScmtThrRS (Phe 49 -Lys 462 ) was similarly obtained by PCR using pET28a-ScmtThrRS as a template and digested by SacI and XhoI. The two fragments were then co-ligated into pET28a pre-cleaved by NdeI and XhoI to obtain pET28a-CmThrRS. For construction of the chimeric CmThrRS2 gene, a DNA fragment encoding Met 1 -His 616 of SccytThrRS (including the N-extension, N1, N2 and aminoacylation domains) was amplified by PCR using pET28a-SccytThrRS as a template and cleaved by NdeI and SacI; a second DNA fragment encoding the C-terminal domains of ScmtThrRS (Gly 339 -Lys 462 ) was obtained by PCR using pET28a-ScmtThrRS as a template and digested by SacI and XhoI. The two fragments were then co-ligated into pET28a (pre-cleaved by NdeI and XhoI) to generate pET28a-CmThrRS2. For subcloning into p425TEF (32), the two genes encoding CmThrRS and CmThrRS2 were PCR amplified, digested and inserted into the gap between the PstI and XhoI of p425TEF to obtain p425TEF-CmThrRS and p425TEF-CmThrRS2.
Genes encoding the ScmtThrRS precursor or mature ScmtThrRS were inserted into the yeast expression vector p425TEF at the PstI and XhoI sites, respectively, to produce the p425TEF-ScmtThrRS precursor (with the MTS) or p425TEF-ScmtThrRS (without the MTS). Genes encoding EcThrRS or SccytThrRS were amplified from the E. coli genome or pET28a(+)-SccytThrRS, respectively, and inserted into the site of HindIII and SalI or PstI and XhoI sites, respectively, in p425TEF. The gene encoding mature CamtThrRS (Ser 29 -Lys 455 ) (27) was amplified from the C. albicans genome, digested by PstI and XhoI and inserted into the complementary sites of p425TEF. Construction of p425TEF-hcThrRS (human cytoplasmic ThrRS) has been described in a previous report (19 
Protein gene expression and purification
E. coli BL21 (DE3) was transformed with various constructs. A single colony of each of the transformants was chosen and cultured in 500 ml of 2× YT medium at 37
• C. When the cells reached mid-log phase (A 600 = 0.6), expression of the recombinant proteins was induced by the addition of 0.2 mM isopropyl-1-thio-␤-D-galactopyranoside for 8 h at 22
• C. Protein purification was performed according to a previously described method (33) .
tRNA gene cloning and transcription
tRNA Thr 1 and tRNA Thr 2 genes were inserted between the PstI and EcoRI sites of pTrc99b downstream of an 5 inserted T7 promoter. All tRNA sequences were confirmed by DNA sequencing. Detailed in vitro T7 run-off transcription of tRNA Thr 1 and tRNA Thr 2 was performed as described previously (34) . The accepting capacity of tRNA Thr 1 and tRNA Thr 2 was 1156 and 1327 pmol/A 260 , respectively. All tRNA mutants were constructed based on the protocol provided with KOD mutagenesis kits and transcribed as tRNA Thr 1 and tRNA Thr 2.
Enzymatic assays
ATP-PPi exchange measurement was carried out at 30
• C in a reaction mixture containing 60 mM Tris-HCl (pH 8.5), 10 mM MgCl 2 , 5 mM DTT, 0.1 mg/ml BSA, 2.5 mM ATP, 2 mM tetrasodium [
32 P]pyrophosphate, 1 mM Thr or 300 mM non-cognate Ser and 200 nM ScmtThrRS or CmThrRS. Aliquots of 15 l were taken and quenched to 200 l with a solution containing 2% activated charcoal, 3.5% HClO 4 and 50 mM tetrasodium pyrophosphate at various time intervals. The solution was filtered through a Whatman GF/C filter, followed by washing with 20 ml of 10 mM tetrasodium pyrophosphate solution and 10 ml of 100% ethanol. The filters were dried and [ 32 P]ATP was measured using a scintillation counter (Beckman Coulter).
Assays of aminoacylation activity of ScmtThrRS or various ThrRSs were performed at 30
• C in a reaction mixture containing 60 mM Tris-HCl (pH 8.5), 10 . Aliquots were taken and quenched on Whatman filter pads pre-soaked with 5% trichloroacetic acid (TCA) at various time intervals. The filters were washed three times for 15 min each in cold 5% TCA and then three times for 10 min each in 100% ethanol. Filters were dried and the radioactivity content of the precipitates was quantified using a scintillation counter (Beckman Coulter).
AMP formation assay
The AMP formation assay (thin-layer chromatography (TLC)) was carried out at 30
• C in a reaction mixture containing 60 mM Tris-HCl (pH 8.5), 10 mM MgCl 2 , 5 mM DTT, 0.1 mg/ml BSA, 10 U/ml pyrophosphatase (PPiase), 40 
Sc MST1 complementation assay
For complementation assays, all genes of interest were recombined into the yeast expression vector, p425TEF as described previously. Plasmids were introduced into Sc MST1 using the lithium acetate (LiAc) procedure (35 (Figure 2) . Therefore, ScmtThrRS must use different tRNA Thr 1-specific recognition elements and patterns (which are absent in EcThrRS and SccytThrRS) to aminoacylate tRNA Thr 1. The most striking feature of the unusual tRNA Thr 1 is the enlarged anticodon loop. We deleted U33a or inserted an additional G36a in the anticodon loop to either reduce or further enlarge the size of the loop, thus, obtaining U33a or ∇G36a ( Figure 3A) . Consistent with data from others (29) , the size reduction decreased the rate of Thr acceptance to ∼70%, suggesting that the 8-nucleotide size of the anticodon loop plays a role in regulating tRNA charging. In contrast, aminoacylation of ∇G36a showed that size enlargement from eight to nine nucleotides slightly increased aminoacylation of the tRNA ( Figure 3B ).
Next, we examined if a U residue at position 33a was critical for a functional enlarged 8-nucleotide anticodon loop. We changed U33a to A, C or G to obtain U33aA, U33aC, U33aG mutants ( Figure 3A) . Aminoacylation assays showed that, compared to wild-type tRNA Thr 1, the U33aC mutation slightly decreased accepting activity, whereas both the U33aA and U33aG mutations decreased the activity considerably ( Figure 3B ). These data showed that a pyrimidine (U or C) at position 33 was more suitable than a purine nucleotide (A or G). A pyrimidine nucleotide might directly interact with ScmtThrRS or alternatively, contribute to anticodon loop plasticity during its interaction with the synthetase. Finally, we mutated each of U34, A35 or G36 of tRNA Thr 1 to the three other nucleotides to obtain U34A, U34C, U34G, A35U, A35C, A35G, G36A, G36C and G36U, respectively ( Figure 3A ). Charging assays showed that mutations at position 34 or 35 had little effect on aminoacylation (data not shown). In contrast, at position 36, the two mutants G36A and G36C showed a significant reduction in aminoacylation, indicating that G36 is an important determinant of ScmtThrRS charging. The third nucleotide, G36U, displayed intact aminoacylation properties ( Figure 3C ). We further calculated aminoacylation kinetics of ScmtThrRS for all the mutants derived from U33a and G36. The data showed that only U33aC and G36U displayed nearly full aminoacylation activity (99.8% and 76%, respectively); however, activity of other mutants decreased to only about 10% of that of wild-type tRNA Thr 1 (Table 1) . Our data were consistent with results of Ling et al., who deleted the U33a or simultaneously mutated A35 and G36 to G and U (obtaining A35G/G36U mutant) and revealed that the inserted U33a played a crucial role in aminoacylation (29) .
ScmtThrRS has isoacceptor-specific tRNA-dependent pretransfer editing activity Recently, it was shown that ScmtThrRS catalyzes the misactivation of non-cognate Ser and uses pre-transfer editing to hydrolyze Ser-AMP (31). However, despite the presence of pre-transfer editing activity against Ser, ScmtThrRS still formed Ser-tRNA Thr in vitro (31) indicating that the editing activity was not sufficient to prevent Ser mis-charging. Here, we performed mis-charging assays with non-cognate Ser and confirmed that both tRNA Thr 1 and tRNA Thr 2 were mis-charged by Ser with a higher rate for tRNA Thr (Table 2 ). These data suggest that ScmtThrRS has little tRNA Thr 1-dependent pre-transfer editing activity ( Figure 5A and B) . In contrast, tRNA Thr 2 stimulated greater tRNA-dependent pre-transfer editing of ScmtThrRS with a k obs of (30.39 ± 2.63) × 10 −3 s −1 ( Figure 5C and D) ( (Table 2) . Therefore, these data indicated that Ser-induced AMP formation was the result of an editing reaction.
Role of anticodon of tRNA
Thr 2 in tRNA-dependent pretransfer editing by ScmtThrRS
In a previous study, we showed that the conserved G35 and U36 are key determinants of editing by SccytThrRS, whereas the discriminator base A73 is of little importance in editing (19) . To check whether this editing recognition mode was conserved in mitochondrial tRNA Thr 2, we mutated G35, U36 and A73 to C, obtaining G35C, U36C and A73C, respectively. The aminoacylation of all the mutants was severely impacted (data not shown), consistent with their function as recognition elements in the EcThrRS and (Table 3 ). In summary, aminoacylationimpaired A73C stimulated a similar level of editing compared with wild-type tRNA Thr 2; thus, A73 is only critical for the synthetic activity, while G35 and U36 play a role in both the aminoacylation and editing activities.
tRNA Thr 1 stimulates pre-transfer editing in the presence of an editing domain
We previously showed that the N2 editing domain of SccytThrRS contributes to both the aminoacylation and editing activities (19) . Therefore, as tRNA Thr 1 was unable to stimulate tRNA-dependent pre-transfer editing, we checked if the absence of the editing domain in ScmtThrRS could explain this incapacity. To address this question, we first added the complete N-terminal domain of the cy- Figure 6A ), despite a decrease in the Thr activation rate to 30% of the wildtype level ( Figure 6B ). Second, we observed that the added editing domain in CmThrRS induced recovery of the posttransfer editing activity as shown by deacylation of SertRNA Thr ( Figure 6C ), thus, CmThrRS accumulated neither Ser-tRNA Thr 1 nor Ser-tRNA Thr 2 ( Figure 4B ). Third, AMP formation was measured in the absence or presence of tRNA Thr 1 in order to clarify whether tRNA Thr 1 was able to stimulate pre-transfer editing by CmThrRS. In the presence of non-cognate Ser, AMP formation was induced significantly in the presence of tRNA Thr 1 with a k obs of (14.30 ± 2.31) × 10 −3 s −1 , which was almost 4-fold higher than k obs in the absence of tRNA Thr 1 (3.59 ± 0.74) × 10 −3 s −1 (Figure 6D and E) . Similarly, tRNA Thr 2 stimulated AMP formation by CmThrRS with an even higher k obs of (20.86 ± 2.10) × 10 −3 s −1 (Table 4) (19) . To verify that the increased AMP formation rate was due to pre-transfer and not post-transfer activity, we mutated residues His 151 and His 155 of the CmThrRS derived from SccytThrRS to Ala residues to produce a mutant CmThrRS-H151A/H155A. As expected, the double mutant was deficient in post-transfer editing activity and could not deacylate preformed Ser-tRNA Thr ( Figure 6C ) but it could still catalyze tRNA Thr 1-or tRNA Thr 2-dependent pretransfer editing with k obs values of (12.75 ± 2.21) × 10
or (14.20 ± 2.67) × 10 −3 s −1 , respectively (Table 4 ) (here, the AMP formation of CmThrRS-H151A/H155A with tRNAs included only pre-transfer editing). In combination, these data suggested that tRNA Thr 1 has the intrinsic capacity to stimulate pre-transfer editing, but requires the presence of a classical editing domain to express this activity. 
Role of the tRNA Thr 1 anticodon in editing by CmThrRS
We previously showed that the anticodon nucleotides of SctRNA Thr or tRNA Thr 2 are critical for the pre-transfer editing activity of SccytThrRS or ScmtThrRS (Table 3 ) (19) . Here we showed that, despite its extended size in anticodon loop, the tRNA Thr 1 stimulated the tRNA-dependent editing activity of CmThrRS in the presence of noncognate Ser. Therefore, to explore the plasticity of the anticodon loop, especially of the 33a UUAG 36 tetranucleotide of tRNA Thr 1 during pre-transfer editing stimulation, we carried out AMP formation assays using the chimeric enzyme CmThrRS in the presence of our constructed U33a, ∇G36a, U33aA, U33aC, U33aG, U34A, U34C, U34G, A35U, A35C, A35G, G36A, G36C or G36U forms of tRNA Thr 1. Results from the editing stimulation assays could be classified into three major categories. Nine of the 14 mutants (∇G36a, U33aC, U33aG, U34A, U34C, U34G, A35U, A35G and G36C) did not have an obvious effect on editing by CmThrRS compared with native tRNA Thr 1 (Table 5). Three mutants ( U33a, A35C and G36A) exhibited decreased (by ∼50%) editing stimulation with k obs values of (7.92 ± 0.94) × 10 −3 s −1 , (7.96 ± 0.87) × 10 −3 s −1 and (8.35 ± 1.32) × 10 −3 s −1 , respectively. Finally, a third category, comprising two mutants (U33aA and G36U) exhibited k obs values of (4.51 ± 0.56) × 10 −3 s −1 and (3.56 ± 0.48) × 10 −3 s −1 , respectively, comparable with that in absence of tRNA (3.59 ± 0.74) × 10 −3 s −1 , which demonstrated the failure of these two mutants to induce significant tRNAdependent editing (Table 5 ). These data indicated that the editing activity of CmThrRS is sensitive to anticodon loop size reduction and to specific mutations of nucleotides 33a, 35 and 36 of tRNA Thr 1. In particular, G36U, which exhibited equivalent aminoacylation activity compared with wild-type tRNA Thr 1 ( Figure 3C and Table 1 ), failed to stimulate any editing, further suggesting that Ser-induced AMP formation was the result of editing but not aminoacylation activity.
The MST1 gene knockout strain, Sc MST1, reveals that aminoacylation and tRNA binding domains co-evolved to acquire tRNA Thr 
recognition capability
Both the primary and tertiary structures of ScmtThrRS and other ThrRSs (such as EcThrRS) are highly similar (Supplementary Figure S1) ; however, only ScmtThrRS has the capacity to acylate tRNA Thr 1, indicating that tRNA Thr 1-specific recognition elements are highly secluded and difficult to identify. Indeed, extensive in vitro structureguided single-point mutagenesis in the C-terminal domain of ScmtThrRS provided some insights but did not reveal critical residues specific only for tRNA Thr 1 (29) . Therefore, we constructed a yeast MST1 gene knockout strain to establish a genetic complementation assay to investigate the in vivo complementation capacity of other ThrRSs and to provide insights into tRNA Thr 1 recognition. We purchased a diploid yeast strain (BY4743-MST1 +/− ) from Thermo Scientific, exhibiting one wild-type copy of MST1, while the other copy was replaced by a kanamycin gene (36) . Strain BY4743-MST1 +/− was transformed with the rescue plasmid [pRS426-MST1, (pRS426: MST1 + , Ura + )] and transformants were cultured on Dropout minimal media minus uracil (SD/Ura − ). Ura + colonies were selected and sporulation was induced. Tetrads were dissected and separated on YPG plates. YPG respiratory and SD/Ura − media supported growth of the haploid MST1-knockout (Sc MST1); however, the strain did not survive on YPG plates supplemented with 5-FOA, the toxic product of which, 5-flurouracil, excluded the rescue plasmid (Supplementary Figure S2A) . This result showed that MST1 is an essential gene for respiratory metabolism. We also confirmed MST1 knockout using a PCR-based method (Supplementary Figure S2B and C) .
We then tested several ThrRSs originating from different organisms in the Sc MST1 strain ( Figure 7A ). The genes of these proteins were recombined into the yeast expression vector p425TEF. The entire ORF of the MST1 precursor was first cloned as well as the protein deprived of its MTS. These constructs, together with the p425TEF empty vector were introduced into Sc MST1 and transformants were grown on YPG and YPG/5-FOA plates. The 5-FOA supplemented respiratory-medium supported growth of clones harboring the gene for the ScmtThrRS precursor only, confirming that the MTS is a critical element for targeting exogenously expressed mature ScmtThrRS into the mitochondrion ( Figure 7B ).
Subsequently, we tested several other natural ThrRSs, including cytosolic SccytThrRS, EcThrRS, mature CamThrRS (Ser 29 -Lys 455 ), hcThrRS and mature hmtThrRS (Leu 20 -Phe 718 ) ( Figure 7A ). Genes encoding these ThrRSs were ligated downstream of the sequence encoding the MTS. Shuffle assays on 5-FOA-medium showed that all these natural ThrRSs were unable to rescue respiratory deficiency ( Figure 7B ). This raises the question of whether the origin of these deficiencies was the lack of tRNA Thr 1 aminoacylation or of mitochondrial import. From our present aminoacylation studies ( Figure 2 ) and reports by others (27) , we know that EcThrRS, SccytThrRS and CamtThrRS readily charge tRNA Thr 2 but not tRNA Thr 1 in vitro. Here, the shuffle assay confirmed that aminoacylation did not occur in vivo either. On the other hand, to further test the mitochondrial import capacity of the MTS with an exogenous ThrRS, we added the MTS upstream of the chimeric CmThrRS that was able to aminoacylate tRNA Thr 1 to form MTS-CmThrRS ( Figure 6A ). The knockout strain was growth-capable under respiratory conditions, showing that MTS-CmThrRS complemented the yeast strain ( Figure 7B ). These data confirmed that the MTS efficiently directed import of the exogenous ThrRS sequence and strongly implied that the natural enzymes were inefficient in aminoacylating tRNA Thr 1 in vivo. Since only the MTS-CmThrRS and ScmtThrRS precursor, both harboring the aminoacylation and C-terminal domains of mitochondrial origin, were able to complement the yeast strain, we speculated that the presence of the mitochondrial C-terminal domain was responsible for in vivo aminoacylation of tRNA Thr 1. To address this question, we replaced the C-terminal domain of SccytThrRS with its counterpart derived from ScmtThrRS to generate CmThrRS2 ( Figure 7A ). Therefore, CmThrRS2 and CmThrRS differed only in the aminoacylation domains, which were of cytoplasmic and mitochondrial origin, respectively ( Figure 7A ). After fusion with the MTS, MTSCmThrRS2 was found to be unable to support mitochondrial protein synthesis in vivo despite comparable levels of CmThrRS and CmThrRS2 protein in Sc MST1 (Supplementary Figure S3) . In vitro aminoacylation data also confirmed that CmThrRS2 charged tRNA Thr not tRNA Thr 1 (Figure 8 ). Therefore, our results indicated that only a ThrRS with both mitochondrial aminoacylation and C-terminal domains are capable of charging tRNA Thr 1, suggesting that the two domains co-evolved to confer tRNA Thr 1 aminoacylation activity.
DISCUSSION
Mitochondrial ThrRS deprived of the editing domain catalyzes tRNA-dependent pre-transfer editing
ThrRS is a class II synthetase with a unique modular structure containing three structural domains. The dimeric core consists mainly of the synthetic catalytic site and the Cterminal tRNA-anticodon binding domain. One extra domain on the N-terminal side of each monomer protrudes outside the core, forming the editing domains of the dimer (37) . Such modular organization is conserved from bacteria (such as E. coli), to higher eukaryotes (such as humans) and in cytoplasmic and mitochondrial compartments. Among them, bacteria and eukaryotic cytoplasmic ThrRSs have been shown to predominantly use post-transfer editing reactions to prevent the synthesis of Ser-tRNA Thr (19, 30) . In the archaeal kingdom, several ThrRSs (such as in Pyrococcus abyssi) use particular editing domains related to D-tyrosyl-tRNA Tyr deacylases to hydrolyze Ser-tRNA Thr (38, 39) . Other archaeal ThrRSs (such as in Sulfolobus solfataricus) are devoid of editing domains; however, editing of Ser-tRNA Thr is maintained and catalyzed by an unrelated free-standing editing domain (40) . All these studies underline the crucial importance of post-transfer editing as a quality control mechanism of the tRNA Thr aminoacylation reaction. Despite this evidence, the N-terminal editing domains of mitochondrial ThrRSs from several yeast species (such as S. cerevisiae, S. pombe and C. albicans) have been lost and these enzymes are defective in post-transfer editing of Ser-tRNA Thr . It was previously shown that S. cerevisiae mitochondrial ThrRS (ScmtThrRS) harbored a tRNA-independent pre-transfer editing activity for hydrolysis of Ser-AMP (31) . In the present study, we showed that ScmtThrRS also possesses a tRNA-dependent pre-transfer activity that is stimulated by tRNA Thr 2 but not tRNA Thr 1. Indeed, AMP formation of ScmtThrRS at the presence of tRNA Thr 2 was ∼4-fold compared with that of without tRNA; however, the unusual tRNA Thr 1 only induced AMP production very modestly. A similar tRNA synthetase, M. mobile LeuRS (MmLeuRS), which also naturally lacks edit-ing domain, exhibits identical AMP formation activity at absence or presence of cognate tRNA Leu (41) . Furthermore, cognate tRNA is unable to stimulate any AMP formation for the editing domain-deprived E. coli LeuRS (EcLeuRSMmLinker) (41) . Therefore, the observed increase in AMP formation activity of ScmtThrRS after tRNA Thr 2 addition is significant and really reflects the tRNA-dependent pretransfer editing of ScmtThrRS, which is defective in posttransfer editing. To our knowledge, this is the first report describing such tRNA-isoacceptor specificity at the pretransfer editing level. However, as reported for EcThrRS (30) , SccytThrRS (19) and other systems (42), pre-transfer editing alone is not sufficient to prevent synthesis of mischarged tRNAs. Therefore, as an error-prone synthetase, ScmtThrRS readily accumulates Ser-tRNA Thr under in vitro conditions. It is possible that synthesized Ser-tRNA Thr is not detrimental to the mitochondrial translational machinery because of efficient discrimination by its elongation factor or the ribosome as is the case in S. cerevisiae cytoplasm (19) . Alternatively, the yeast mitochondrion tolerates amino acid mis-incorporation to a certain extent. Indeed, under some conditions, tRNA mis-charging and amino acid mis-incorporation provides evolutionary benefits to bacteria, yeast or humans (43, 44) .
Our study also showed that tRNA Thr 1 has the intrinsic capacity to stimulate tRNA-dependent pre-transfer editing activity according to the presence of the editing domain added in the chimeric enzyme CmThrRS. Indeed, it has been shown that the editing domain of bacterial ThrRS provides a binding interface for the minor groove of the tRNA acceptor stem and that deletion of the editing domain results in a dimeric enzyme that retains full activity in the activation step, while it is less efficient in the tRNA charging step (37) . Similarly, we have previously found that deleting the N-terminal editing domain from yeast ThrRS results in an aminoacylation-impaired mutant; furthermore, amino acid alteration in the editing domain has an obviously negative effect on tRNA-dependent pre-transfer editing by yeast SccytThrRS (19) . Collectively, these data indicate the critical contribution of the editing domain to aminoacylation and tRNA-dependent pre-transfer editing, possibly mediated by binding the acceptor stem of tRNA. The stimulation effect of chimeric CmThrRS observed here strongly suggests that interaction with the added editing domain may stabilize tRNA Thr 1 in a conformation that is suitable for pre-transfer editing.
For tRNA Thr 2-dependent pre-transfer editing, we found that both G35 and U36, but not A73 are key positive determinants. This is consistent with the cytosolic SccytThrRS, which depends critically on recognition of the anticodon bases for quality control (19) . However, for the tRNA Thr 1-dependent pre-transfer editing catalyzed by the chimeric CmThrRS, we showed the critical importance of different bases in the anticodon loop, such as U33a and G36, which suggests differences in the anticodon loop-binding mode between the two tRNAs during editing.
tRNA-dependent pre-transfer editing is likely to occur at the aminoacylation active site
The location of the tRNA-dependent pre-transfer editing site has been debated. Preliminary evidence indicated that tRNA-dependent pre-transfer editing takes place in the editing domain, which is also the site of the post-transfer editing reaction. Indeed, fluorescence translocation-based assays combined with structure-directed mutagenesis in the CP1 editing domain of class Ia isoleucyl-tRNA synthetase (IleRS) showed that the tRNA Ile -dependent hydrolysis of Val-AMP occurs in the CP1 domain (10) (11) 16 ). This observation was consistent with the X-ray crystal structures showing that both the substrate of pre-and post-transfer editing bind the CP1 editing site with overlapping sites in LeuRS (12) . In addition, a potential translocation channel was detected between the enzyme and tRNA, which could explain the migration of the adenylate molecules from the aminoacylation synthetic active site to the editing site (14, 15) . However, several reports indicated that tRNAdependent pre-transfer editing occurs in the aminoacylation domain. This was first observed for GlnRS, a class I enzyme naturally devoid of a specialized editing domain, but able to catalyze tRNA-dependent aminoacyl-adenylate hydrolysis in the presence of a tRNA analog (17) . Similarly, covalent inactivation of the E. coli LeuRS editing site by compound AN2690 did not reduce tRNA-dependent pre-transfer editing, indicating that the synthetic site was likely to be involved in tRNA-dependent pre-transfer editing (42) . Furthermore, SccytThrRS-H151A/H155A, which harbored a defective editing domain, obviously catalyzed tRNA-dependent pre-transfer editing (19) . However, these examples are subject to the criticism that analogs, inhibitors or mutations never mediate complete and definitive inactivation of the editing site, leading to careful and cautious interpretations. In the present study, we showed that ScmtThrRS, a naturally occurring enzyme without a posttransfer editing domain, catalyzes significant tRNA Thr 2-dependent pre-transfer editing; therefore, representing a perfect model to study the mechanism of tRNA-dependent pre-transfer editing without contaminating post-transfer editing activity. In addition, it directly suggests that, at least for ScmtThrRS, tRNA-dependent pre-transfer editing takes place in the aminoacylation domain where the cognate and non-cognate adenylate molecules are synthesized.
Specific binding mode of mitochondrial tRNA Thr 1 to ScmtThrRS
As stated previously, many yeast mitochondrial ThrRSs lack editing domains, suggesting that the loss of the editing domain occurred before the divergence of these species. Strikingly, both S. pombe and C. albicans mitochondria have retained canonical tRNA Leu Thr 1-specific recognition elements. A crystal structure-based Ala-scanning mutagenesis strategy targeting all potential arginine or lysine residues has been employed to identify specific recognition sites for tRNA Thr 1 in the anticodon binding domain of ScmtThrRS (29) . Among them, mutant R434A displayed specifically reduced affinity for tRNA Thr 1, suggesting that this residue is a critical element of tRNA Thr discrimination. However, Arg 434 is a highly conserved residue present in nearly all ThrRSs (Supplementary Figure S1 ), including EcThrRS, SccytThrRS, SpmtThrRS, CamtThrRS, hcThrRS and hmtThrRS, all of which were unable to charge tRNA Thr 1. This suggests that Arg 434 is only one element in a tRNA Thr discrimination network, the whole process of which is probably more complex than expected. Our in vivo data generated with chimeric enzymes showed that the acquisition of tRNA Thr 1 aminoacylation required the presence of both yeast mitochondrial aminoacylation and tRNA binding domains, suggesting that both domains co-evolved to follow the CUN codon reassignment and recognition of the new anticodon loop. Therefore, the strategy of Ala-scanning of amino acid targets may be extended to the aminoacylation domain. In this study, we observed another remarkable difference characterizing the two tRNA Thr isoacceptors. While tRNA Thr 2 spontaneously catalyzes tRNA-dependent pretransfer editing, tRNA Thr 1 required the artificial presence of an editing domain to stimulate pre-transfer editing. As the editing and aminoacylation domains usually clamp the acceptor stem of tRNA Thr , this strongly suggests differences in the interaction of the acceptor end of the two tRNAs with the aminoacylation domain. This also implies the existence of tRNA Thr isoacceptor-specific interaction elements with the aminoacylation domain. Further peptide swapping and site-directed point mutagenesis will be performed in this domain to identify residues that potentially interact with tRNA Thr 1 and may be part of the specific subset of amino acids involved in the recognition process.
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